Hazards, Risks, and Threats of Heart Disease from the Early Stages to Symptomatic Coronary Heart Disease and Cardiac Failure William B. Kannel OriginalPaper Pages: 199 - 212
Oral Nitrates: More Than Symptomatic Therapy in Coronary Artery Disease? Udho Thadani OriginalPaper Pages: 213 - 218
Detection of Myocardial Damage by Serial Measurements of Cardiac Troponin T, CK MBmass, and TROPT Rapid Test Willie GerhardtLars Ljungdahl OriginalPaper Pages: 227 - 240
Pharmacology of Carvedilol: Rationale for Use in Hypertension, Coronary Artery Disease, and Congestive Heart Failure Robert R. Ruffolo Jr.Giora Z. Feuerstein OriginalPaper Pages: 247 - 256
Retardation of Coronary Atherosclerosis: The Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT) and Other Angiographic Trials Ulf De FaireCarl-Göran EricssonAnders Hamsten OriginalPaper Pages: 257 - 263
Diuretics in the Prevention and Treatment of Congestestive Heart Failure Marvin Moser OriginalPaper Pages: 273 - 277
ACE Inhibitors in Heart Failure: Prospects and Limitations Bertram Pitt OriginalPaper Pages: 285 - 290
Second- and Third-Generation Beta-Blocking Drugs in Chronic Heart Failure Michael R. BristowWilliam T. AbrahamEdward M. Gilbert OriginalPaper Pages: 291 - 296
Combination Drug Therapy in Chronic Heart Failure: Is Treatment Part of the Problem in Heart Failure? John G.F. Cleland OriginalPaper Pages: 297 - 303